483 related articles for article (PubMed ID: 11504284)
1. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
2. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.
Miller AR; Pisters PW; Lee JE; Janjan NA; Abbruzzese JL; Evans DB
Hepatogastroenterology; 1998; 45(21):624-33. PubMed ID: 9684107
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
Meszoely IM; Wang H; Hoffman JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?
Pasetto LM; Jirillo A; Stefani M; Monfardini S
Anticancer Res; 2003; 23(3C):2805-13. PubMed ID: 12926117
[TBL] [Abstract][Full Text] [Related]
8. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
9. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
10. Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms.
Evans OB; Abbruzzese JL; Cleary KR; Lee JE; Buchholz DJ; Rich TA
J R Coll Surg Edinb; 1995 Oct; 40(5):319-23. PubMed ID: 8523311
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.
Staley CA; Lee JE; Cleary KR; Abbruzzese JL; Fenoglio CJ; Rich TA; Evans DB
Am J Surg; 1996 Jan; 171(1):118-24; discussion 124-5. PubMed ID: 8554125
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
White RR; Kattan MW; Haney JC; Clary BM; Pappas TN; Tyler DS; Brennan MF
Ann Surg Oncol; 2006 Nov; 13(11):1485-92. PubMed ID: 17013688
[TBL] [Abstract][Full Text] [Related]
14. The case for routine use of adjuvant therapy in pancreatic cancer.
Kennedy EP; Yeo CJ
J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant therapies in combination with pancreatectomy for carcinoma of the pancreas].
Ishikawa O; Ohigashi H; Sasaki Y; Furukawa H; Kabuto T; Imaoka S; Iwanaga T; Nakaizumi A; Uehara H; Matayoshi Y
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1635-41. PubMed ID: 8886033
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary management of resectable adenocarcinoma of the pancreatic head.
Yamamoto M; Imagawa DK; Katz MH
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1611-21. PubMed ID: 18925853
[TBL] [Abstract][Full Text] [Related]
18. Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation.
Wayne JD; Abdalla EK; Wolff RA; Crane CH; Pisters PW; Evans DB
Oncologist; 2002; 7(1):34-45. PubMed ID: 11854545
[TBL] [Abstract][Full Text] [Related]
19. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
20. Current approaches to multimodality management of advanced pancreatic cancer.
Douglass HO
Hepatogastroenterology; 1993 Oct; 40(5):433-42. PubMed ID: 8270232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]